论文部分内容阅读
目的:探讨布地奈德佐治小儿肺炎的临床疗效。方法:将我院2010年1月到2011年1月两个月间收治的80例肺炎患儿随机分为对照组与治疗组,每组40例,对照组给予抗感染、吸氧、吸痰、镇静、静脉输液等常规治疗,治疗组在对照组基础上给予布地奈德雾化吸入治疗,两组均连续用药7d,评价临床疗效,统计两组患者的临床症状消失时间以及不良反应发生率。结果:治疗组的显效率和总有效率均明显高于对照组(P<0.05);治疗组主要临床症状消失时间明显短于对照组(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论:布地奈德雾化吸入佐治小儿肺炎的临床疗效确切,治疗时间短,不良反应小,值得推广应用。
Objective: To investigate the clinical efficacy of budesonide adjuvant pediatric pneumonia. Methods: 80 cases of children with pneumonia admitted in our hospital from January 2010 to January 2011 were randomly divided into control group and treatment group, 40 cases in each group. The control group was given anti-infection, oxygen inhalation and suctioning , Sedation, intravenous infusion and other conventional treatment, the treatment group on the basis of the control group budesonide inhalation therapy, two groups were continuous medication 7d, evaluation of clinical efficacy, statistics of two groups of patients with clinical symptoms disappear time and the incidence of adverse reactions . Results: The effective rate and total effective rate in the treatment group were significantly higher than those in the control group (P <0.05). The disappearance time of the main clinical symptoms in the treatment group was significantly shorter than that in the control group (P <0.05). There was no significant difference in adverse reactions between the two groups Statistical significance (P> 0.05). Conclusion: The efficacy of budesonide aerosol inhalation for pediatric pneumonia is definite, the treatment time is short, and the adverse reactions are small, which is worth popularizing and applying.